Seneca Biopharma, Inc.

Seneca Biopharma, Inc., (NASDAQ: SNCA) is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Seneca is in the process of finding and acquiring new assets, promising sciences and technologies that will provide meaningful therapies for patients.

About Us

Finding Promising New Science and Developing a Pipeline of Biopharmaceuticals

Seneca Biopharma is focused on finding promising new science and developing a pipeline of biopharmaceuticals and commercializing those products while creating value for our stakeholders.

Our Technology Platform & Pipeline

Identifying new opportunities: Seneca Bio is focused on the continued development of its current technologies and has also engaged a network of trusted experts and advisors to assist us in evaluating new technologies.

Our Pipeline

Contact Us

Do you have questions about our company, our efforts or partnership opportunities?

Contact Us
Email Sign Up

Sign me up for:

Stock Information